Lebenthal Global Advisors LLC Lowers Stock Position in Inspire Medical Systems, Inc. (NYSE:INSP)

Lebenthal Global Advisors LLC lessened its holdings in Inspire Medical Systems, Inc. (NYSE:INSP) by 3.7% in the 4th quarter, Holdings Channel.com reports. The firm owned 2,615 shares of the company’s stock after selling 100 shares during the quarter. Lebenthal Global Advisors LLC’s holdings in Inspire Medical Systems were worth $485,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of INSP. Amalgamated Bank lifted its stake in Inspire Medical Systems by 4.1% in the 2nd quarter. Amalgamated Bank now owns 2,005 shares of the company’s stock valued at $268,000 after buying an additional 79 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its stake in shares of Inspire Medical Systems by 1.0% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 7,879 shares of the company’s stock worth $1,461,000 after acquiring an additional 79 shares during the last quarter. Signaturefd LLC increased its position in shares of Inspire Medical Systems by 45.9% during the third quarter. Signaturefd LLC now owns 270 shares of the company’s stock worth $57,000 after purchasing an additional 85 shares in the last quarter. The Manufacturers Life Insurance Company raised its stake in Inspire Medical Systems by 0.4% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 21,193 shares of the company’s stock valued at $2,836,000 after purchasing an additional 92 shares during the last quarter. Finally, Nisa Investment Advisors LLC lifted its holdings in Inspire Medical Systems by 37.3% in the 4th quarter. Nisa Investment Advisors LLC now owns 368 shares of the company’s stock valued at $68,000 after purchasing an additional 100 shares in the last quarter. Institutional investors and hedge funds own 94.91% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently commented on INSP. Piper Sandler reiterated an “overweight” rating and issued a $260.00 target price (up from $255.00) on shares of Inspire Medical Systems in a research report on Tuesday, November 5th. Robert W. Baird increased their price objective on shares of Inspire Medical Systems from $240.00 to $252.00 and gave the company an “outperform” rating in a report on Tuesday, November 5th. Royal Bank of Canada restated an “outperform” rating and set a $260.00 target price on shares of Inspire Medical Systems in a report on Tuesday, November 5th. Truist Financial reiterated a “buy” rating and set a $240.00 price objective (up previously from $217.00) on shares of Inspire Medical Systems in a research report on Monday, September 30th. Finally, Bank of America upgraded Inspire Medical Systems from a “neutral” rating to a “buy” rating and upped their target price for the company from $220.00 to $255.00 in a report on Wednesday, November 20th. Three analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat, Inspire Medical Systems has a consensus rating of “Moderate Buy” and an average target price of $231.45.

Inspire Medical Systems Stock Performance

Shares of INSP opened at $184.49 on Tuesday. The company’s 50-day simple moving average is $189.32 and its 200-day simple moving average is $187.20. Inspire Medical Systems, Inc. has a 1 year low of $123.00 and a 1 year high of $257.40. The stock has a market capitalization of $5.53 billion, a PE ratio of 172.42 and a beta of 1.32.

Inspire Medical Systems (NYSE:INSP) last released its earnings results on Monday, November 4th. The company reported $0.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.06 by $0.54. The company had revenue of $203.20 million for the quarter, compared to analyst estimates of $197.59 million. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%. The firm’s quarterly revenue was up 32.6% on a year-over-year basis. During the same period in the prior year, the business earned ($0.29) EPS. On average, sell-side analysts predict that Inspire Medical Systems, Inc. will post 1.35 earnings per share for the current year.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.